Document is current
Any future updates will be listed below
-
Authors
Miller, Rachel E. https://orcid.org/0000-0002-4486-5757
Scanzello, Carla R. https://orcid.org/0000-0002-9290-188X
Malfait, Anne-Marie https://orcid.org/0000-0003-1428-0384
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K01AR070328)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR064251)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR060364)
Rehabilitation Research and Development Service (RX001757)
- License Information
-
More Information
Article History
Received: 8 April 2019
Accepted: 9 September 2019
First Online: 14 October 2019
Compliance with ethical standards
:
: R. E. Miller and C.R. Scanzello have no conflicts to declare. A.M. Malfait has received research funding from Galapagos N.V. and from GSK, and consulting fees from Eli-Lilly/Pfizer, EMD Serono, and Vizuri.
